
Therapeutic Area | MeSH |
|---|---|
| nutritional and metabolic diseases | D009750 |
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| CARNITOR | Leadiant Biosciences | N-018948 RX | 1985-12-27 | 1 products, RLD, RS |
| CARNITOR | Leadiant Biosciences | N-020182 RX | 1992-12-16 | 1 products, RLD, RS |
| CARNITOR | Leadiant Biosciences | N-019257 RX | 1986-04-10 | 1 products, RLD, RS |
| CARNITOR SF | Leadiant Biosciences | N-019257 RX | 2007-03-28 | 1 products, RLD |
Brand Name | Status | Last Update |
|---|---|---|
| carnitor | New Drug Application | 2024-10-30 |
| carnitor sf | New Drug Application | 2024-11-04 |
| levocarnitine | ANDA | 2025-07-17 |
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| deficiency diseases | EFO_1001067 | D003677 | E63 |
Code | Description |
|---|---|
| J1955 | Injection, levocarnitine, per 1 gm |

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | — | 1 | — | 1 | 2 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | — | 1 | — | — | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Muscular atrophy | D009133 | — | — | 1 | 2 | — | — | — | 2 |
| Spinal muscular atrophy | D009134 | EFO_0003823 | G12.1 | 1 | 2 | — | — | — | 2 |
| Atrophy | D001284 | — | — | 1 | 2 | — | — | — | 2 |
| Spinal muscular atrophies of childhood | D014897 | Orphanet_83419 | G12.1 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | — | — | — | — | 1 | 1 |
| Hypoglycemia | D007003 | — | E16.2 | — | — | — | — | 1 | 1 |
| Drug common name | Levocarnitine |
| INN | levocarnitine |
| Description | Carnitine is an amino-acid betaine that is butanoate substituted with a hydroxy group at position C-3 and a trimethylammonium group at C-4. It has a role as a human metabolite and a mouse metabolite. It is functionally related to a butyrate. It is a conjugate base of a carnitinium. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | C[N+](C)(C)C[C@H](O)CC(=O)[O-] |
| PDB | — |
| CAS-ID | 541-15-1 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1149 |
| ChEBI ID | 16347 |
| PubChem CID | 288 |
| DrugBank | DB00583 |
| UNII ID | 0G389FZZ9M (ChemIDplus, GSRS) |






